2/9
07:00 am
zura
Zura Bio (NASDAQ:ZURA) is now covered by analysts at Wedbush. They set an "outperform" rating and a $15.00 price target on the stock.
Medium
Report
Zura Bio (NASDAQ:ZURA) is now covered by analysts at Wedbush. They set an "outperform" rating and a $15.00 price target on the stock.
2/4
06:30 am
zura
Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit
Medium
Report
Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit
1/21
08:50 am
zura
Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer
High
Report
Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer
1/13
04:06 am
zura
Zura Bio (NASDAQ:ZURA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Neutral
Report
Zura Bio (NASDAQ:ZURA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/12
06:30 am
zura
Zura Bio Reports Business Updates and Outlook for 2026
Low
Report
Zura Bio Reports Business Updates and Outlook for 2026
11/25
07:32 am
zura
Zura Bio (NASDAQ:ZURA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Low
Report
Zura Bio (NASDAQ:ZURA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.